Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology (CGON) has disclosed Preferred Dividend Payments for 1 consecutive years, with $5.9 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Preferred Dividend Payments changed N/A year-over-year to $5.9 million, compared with a TTM value of $11.3 million through Dec 2024, down 39.99%, and an annual FY2023 reading of $18.8 million, changed N/A over the prior year.
  • Preferred Dividend Payments was $5.9 million for Q4 2023 at CG Oncology, up from $5.3 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $5.9 million in Q4 2023 and bottomed at $3.7 million in Q1 2023.